P

Inventor

ITO YOSHITERU

JP29 patents
⚠️ This page may combine multiple inventors who share the name “ITO YOSHITERU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAKEDA PHARMACEUTICALS CO

21 patents
US10584097B2Mar 10, 2020

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO14 citations94
US10428023B2Oct 1, 2019

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO22 citations94
US11440883B2Sep 13, 2022

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO3 citations73
US11655241B2May 23, 2023

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO2 citations72
US11319286B2May 3, 2022

Heterocyclic compound and application thereof

TAKEDA PHARMACEUTICALS CO4 citations72
US10981934B2Apr 20, 2021

Fused heterocyclic compound

TAKEDA PHARMACEUTICALS CO1 citations72
US10577382B2Mar 3, 2020

Fused heterocyclic compound

TAKEDA PHARMACEUTICALS CO3 citations72
US11230545B2Jan 25, 2022

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations71
US12421188B2Sep 23, 2025

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO0 citations62
US12415782B2Sep 16, 2025

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO0 citations62
US12404237B2Sep 2, 2025

Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives

TAKEDA PHARMACEUTICALS CO0 citations62
US12358879B2Jul 15, 2025

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations61
US11390634B2Jul 19, 2022

Fused heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations61
US12152027B2Nov 26, 2024

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations60
US11897879B2Feb 13, 2024

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations60
US12534471B2Jan 27, 2026

Pyrrolo[1, 2-c]imidazole derivatives as orexin type 2 receptor agonists and methods of use thereof

TAKEDA PHARMACEUTICALS CO0 citations59
US11987586B1May 21, 2024

Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists

TAKEDA PHARMACEUTICALS CO1 citations59
US9624184B2Apr 18, 2017

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO1 citations51
US12448377B2Oct 21, 2025

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations50
US12091410B2Sep 17, 2024

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations50
US12071434B2Aug 27, 2024

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations50

MATSUSHITA ELECTRIC INDUSTRIAL CO LTD

3 patents

FUJI PHOTO FILM CO LTD

2 patents

TAKEDA PHARMACEUTICAL

1 patent

SEKISUI JUSHI KK

1 patent

MAKITA CORP

1 patent